by Amy Cook | Jul 31, 2025 | Healthcare, News
Roosa joins the executive team to strengthen strategic initiatives surrounding laboratory licensing of the EPISEEK multicancer early detection tests and other laboratory products. Tucson, AZ — Precision Epigenomics is pleased to announce that Nannon Roosa will join...
by pesbm-sam | Feb 14, 2024 | Healthcare
Precision Epigenomics Inc. presents a bioinformatics study…
by pesbm-sam | Feb 10, 2024 | Healthcare
Precision Epigenomics Inc. presents a pilot study of the performance of EPISEEK™ for hepatocellular carcinoma at the Digestive Disease Week Annual Meeting 2023 in Chicago
by pesbm-sam | Feb 8, 2024 | Healthcare
Precision Epigenomics Inc. presents results of the performance of the EPISEEK-MPE™ test at the annual American Thoracic Society meeting 2023 in Washington, DC
by pesbm-sam | Feb 22, 2022 | Healthcare
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic…
by pesbm-sam | Apr 10, 2021 | Healthcare
Precision Epigenomics Inc was selected to present their findings regarding the development of a liquid biopsy assay for non-small cell lung to the leadership and faculty of the University of Arizona.
